Zell | $589,875 | (Apr 14, 2026)
Qoro | $750,000 | (Apr 14, 2026)
Remission Medical | Undisclosed Amount | (Apr 14, 2026)
Certified by Founder
Lodge
Astrocyte Pharmaceuticals
start up
United States
- Groton, Connecticut
- 22/08/2023
- Pre-Series B
- $6,000,000
Astrocyte Pharmaceuticals is a clinical-stage drug discovery and development company dedicated to accelerating the recovery and well-being of brain injury patients. Astrocyte is committed to proving the neuro- and cerebroprotective benefits of enhanced mitochondrial energy production in astrocytes, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
- Industry Biotechnology Research
- Website https://www.astrocytepharma.com/
- LinkedIn https://www.linkedin.com/company/astrocytepharma/about/
Pixel Photonics | $5,880,875 | (Apr 14, 2026)
Critical Loop | $26,000,000 | (Apr 14, 2026)
AIRMO | $5,880,175 | (Apr 14, 2026)
Primepoint | $10,000,000 | (Apr 14, 2026)
Blocks | $6,000,000 | (Apr 14, 2026)
Slate Auto | $650,000,000 | (Apr 14, 2026)
Quartzy | $23,000,000 | (Apr 14, 2026)
Citra Space Corporation | $15,000,000 | (Apr 14, 2026)
Flashpass | $4,250,000 | (Apr 14, 2026)